Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Endothelial Cells”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableNot Yet RecruitingNCT07697235
What this trial is testing

Impact of an Optimized Omega-3 Formulation on Inflammation and Endothelial Dysfunction in Pulmonary Arterial Hypertension

Who this might be right for
PAH
University Hospital, Strasbourg, France 22
Not applicableUnknownNCT01773200
What this trial is testing

Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage

Who this might be right for
Aneurysmal Subarachnoid Hemorrhage
Centre Hospitalier Universitaire de Besancon 92
Not applicableStudy completedNCT04701385
What this trial is testing

Plaque Erosion Prospective Study ii

Who this might be right for
Atheroma; Myocardial
Norfolk and Norwich University Hospitals NHS Foundation Trust 33
Not applicableStudy completedNCT01038700
What this trial is testing

Circulating Endothelial Compartment During Normal and Pathological Aging

Who this might be right for
Healthy
Assistance Publique - Hôpitaux de Paris 84
Not applicableStudy completedNCT07807683
What this trial is testing

Circulating Endothelial Cells (CECs) as Potential Predictive/Prognostic Biomarkers in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Centro di Riferimento Oncologico - Aviano 148
Post-approval studies (Phase 4)UnknownNCT02693470
What this trial is testing

The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)

Who this might be right for
Psoriasis With Cell-derived Microparticles
Chang Gung Memorial Hospital 100
Not applicableUnknownNCT03195569
What this trial is testing

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 15
Post-approval studies (Phase 4)Study completedNCT01212653
What this trial is testing

Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)

Who this might be right for
Ankylosing Spondylitis(AS)
Chinese University of Hong Kong 50
Post-approval studies (Phase 4)Study completedNCT02487732
What this trial is testing

Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting

Who this might be right for
Acute Coronary Syndrome
Korea University Anam Hospital 60
Not applicableStudy completedNCT00325871
What this trial is testing

Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Mackay Memorial Hospital 30
Not applicableStudy completedNCT00272571
What this trial is testing

The Effects of External Counter Pulsation Therapy on Circulating Endothelial Progenitor Cells

Who this might be right for
Coronary Artery Disease
Sheba Medical Center 25
Large-scale testing (Phase 3)UnknownNCT02029209
What this trial is testing

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 110
Not applicableUnknownNCT02347540
What this trial is testing

Heart Failure and Related Risk-factors After Preeclampsia

Who this might be right for
Heart FailureCardiovascular DiseasesPre-Eclampsia
Maastricht University Medical Center 2,580
Post-approval studies (Phase 4)Study completedNCT01952756
What this trial is testing

Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)

Who this might be right for
Peripheral Arterial Diseases
National Cheng-Kung University Hospital 44
Not applicableStudy completedNCT02157896
What this trial is testing

Vascular Endothelial Growth Factor and Endostatin in Angiogenesis After Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Shanghai 6th People's Hospital 30
Post-approval studies (Phase 4)Ended earlyNCT05139914
What this trial is testing

Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Endothelial Dysfunction
Boston University 4
Testing effectiveness (Phase 2)WithdrawnNCT02148367
What this trial is testing

Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI

Who this might be right for
Traumatic Brain Injury
Uniformed Services University of the Health Sciences
Large-scale testing (Phase 3)Study completedNCT00826683
What this trial is testing

Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung CancerChronic Obstructive Pulmonary Disease
University Hospital, Limoges 140
Not applicableStudy completedNCT05169502
What this trial is testing

Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing

Who this might be right for
DiabetesDiabetes MellitusProliferative Diabetic Retinopathy+2 more
Aarhus University Hospital 40
Not applicableStudy completedNCT02694575
What this trial is testing

The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Diseases
University of Leicester 241
Next Page